Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2012
12/06/2012US20120308676 Antiviral composition containing an aleurites fordii or daphne kiusiana extract or a fraction thereof as an active ingredient
12/06/2012US20120308670 Topical Medicament for the Treatment of Psoriasis
12/06/2012US20120308660 Nanocoatings for biological materials
12/06/2012US20120308653 Wormwood pill containing 95% of wormwood ethyl alcohol extract that has inactivation efficacy of the h1n1 virus and the h9n2 avian influenza virus
12/06/2012US20120308652 Oral form of administration comprising entecavir
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308642 Inhibiting hepatitis c viral replication with sirna combinations
12/06/2012US20120308638 Antimicrobial peptides
12/06/2012US20120308637 Compositions comprising extracts of boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith
12/06/2012US20120308633 Nanostructured material formulated with bone cement for effective antibiotic delivery
12/06/2012US20120308627 Liquid-filled protein-phosphatidic acid capsule dispersions
12/06/2012US20120308623 Composition comprising nanoparticles of ti02
12/06/2012US20120308618 Ic31 nanoparticles
12/06/2012US20120308615 Formulation of hepatitis b virus antigens for cellular stimulation followed by therapeutic immunization
12/06/2012US20120308608 Interferon-inducing compounds and uses thereof
12/06/2012US20120308607 Production and use of human cd124- and cd-116-positive tumor cell lines in the production of allogenic or semi-allogenic immunotherapy agents
12/06/2012US20120308603 Dna vaccine against virus of yellow fever
12/06/2012US20120308602 Recombinant RSV Virus Expression Systems And Vaccines
12/06/2012US20120308600 Polysaccharide immunogens conjugated to e. coli carrier proteins
12/06/2012US20120308597 Serologic correlates of protection against bacillis anthracis infection
12/06/2012US20120308596 Novel streptococcus antigens
12/06/2012US20120308595 Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease
12/06/2012US20120308594 Hcv clade and prototype sequences thereof
12/06/2012US20120308593 Immunological Compositions for HIV
12/06/2012US20120308592 Immunogenic HPV L2-Containing VLPs and Related Compositions, Constructs, and Therapeutic Methods
12/06/2012US20120308589 Sinomenine derivatives, synthetic methods and uses thereof
12/06/2012US20120308586 Composition based on extra virgin olive oils
12/06/2012US20120308581 Compositions and methods for detecting tlr3
12/06/2012US20120308580 Hepatitus b virus specific antibody and usese thereof
12/06/2012US20120308579 Method of making and using a composition for delivering viral immunogen immunoglobulin inhibitor to the nasal pharyngeal membrane
12/06/2012US20120308552 Hemostatic bio-material composition and method
12/06/2012US20120308538 Preventing spoilage in alcohol fermentations
12/06/2012US20120308535 Pharmaceutical Composition Containing Expanded Adult Stem Cells and Methods of Using Same for Treatment
12/06/2012US20120308528 Methods and Compositions for Gene Inactivation
12/06/2012US20120308527 Prevention of opportunistic infections in immune-comprised subjects
12/06/2012US20120308525 Nutritional compositions including a high protein component and exogenous nucleotides
12/06/2012US20120308520 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
12/06/2012US20120308519 Anti-Arenaviral Compounds
12/06/2012US20120308517 Compositions for the treatment of infectious and tumoural diseases
12/06/2012US20120308515 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response
12/06/2012CA2838023A1 Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
12/06/2012CA2837759A1 Novel antibacterial combination therapy
12/06/2012CA2837481A1 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
12/06/2012CA2837279A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain
12/06/2012CA2837125A1 Combined vaccines for prevention of porcine virus infections
12/06/2012CA2836511A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012CA2835272A1 Pharmaceutical antiretroviral composition
12/05/2012EP2530075A2 Modulators of ATP-binding cassette transporters
12/05/2012EP2529793A2 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria
12/05/2012EP2529737A1 Antibacterial combination therapy
12/05/2012EP2529733A1 Antibacterial combination therapy
12/05/2012EP2529728A1 Pharmaceutical compositions for the treatment of bacterial infections
12/05/2012EP2528939A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
12/05/2012EP2528926A1 Hepatitis c inhibitor compounds
12/05/2012EP2528922A1 Polyheterocyclic compounds highly potent as hcv inhibitors
12/05/2012EP2528904A1 Production and use of antibacterial, antiproliferative, and antiphytopathogenic benzanthracenes
12/05/2012EP2528624A1 Extracellular ifi16 as therapeutic agents
12/05/2012EP2528593A2 Effervescent formulations comprising cefprozil as active agent
12/05/2012EP2528591A2 Effervescent formulations comprising cefaclor
12/05/2012EP2528590A2 Effervescent dosage forms comprising cephalosporin antibiotic
12/05/2012EP2528589A2 Stable efervescent formulations comprising cefaclor
12/05/2012CN202568934U Tablet capsule filled with glipizide solid preparations and metformin solid preparations
12/05/2012CN202568921U Vagina film special for women
12/05/2012CN202566566U Handmade Chinese medicinal bamboo charcoal insole
12/05/2012CN1976704B Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
12/05/2012CN1437479B Recombinant intracellular pathogen vaccines and methods for use
12/05/2012CN102812023A Anti - infective pyrido (1,2 -a) pyrimidines
12/05/2012CN102812007A Therapeutic agent for hepatitis C
12/05/2012CN102811998A New Inhibitors Of Cyclophilins And Uses Thereof
12/05/2012CN102811733A Bacteremia-associated Antigen From Staphylococcus Aureus
12/05/2012CN102811724A Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
12/05/2012CN102807989A Preparation method of recombination live vector vaccines for diseases of canid and/or feline
12/05/2012CN102807972A Hepatitis A virus purification method
12/05/2012CN102807621A Fusion protein containing diphtheria toxin non-toxic mutant cross-reacting material 197 (CRM197) or segment thereof
12/05/2012CN102807617A Antibodies to M-CSF
12/05/2012CN102807613A Secreted protein with chemotactic activity and medicament usage thereof
12/05/2012CN102807610A Antibacterial peptides and application of antibacterial peptides to preparation of medicament resisting drug-resistant bacteria
12/05/2012CN102807608A Peptide sequences and compositions
12/05/2012CN102807607A Fused ring heterocycle compound for restraining hepatitis c virus, midbody and application of fused ring heterocycle compound
12/05/2012CN102807526A Preparation method and application of histone deacetylase inhibitor ZYJ-D08a and epimer thereof
12/05/2012CN102805872A HBV-heat shock protein 70 fusion gene vaccine delivered by attenuated salmonella typhimurium, and preparation and application thereof
12/05/2012CN102805868A Method of treatment using ligand-immunogen conjugates
12/05/2012CN102805866A Pharmaceutic preparation for livestock and application thereof
12/05/2012CN102805864A Newcastle disease and H9N2 subtype avian influenza bivalent inactivated vaccine and preparation method thereof
12/05/2012CN102805863A Preparation method of novel bunyavirus purification inactivated vaccine by culturing human diploid cell
12/05/2012CN102805862A Preparation method for SFTS bunyavirus purification and inactivation vaccines through VERO cell culture
12/05/2012CN102805832A External medicament for treating dermatophytosis and preparation method thereof
12/05/2012CN102805831A Medical disinfectant and preparing method thereof
12/05/2012CN102805810A Chinese medicinal preparation for treating acquired immune deficiency syndrome (AIDS) and preparation method thereof
12/05/2012CN102805809A Oral liquid for treating infant myocarditis
12/05/2012CN102805793A Oral Chinese medicinal pill for treating osteomyelitis
12/05/2012CN102805783A Decoction drug for treating impetigo
12/05/2012CN102805776A Traditional Chinese medicine composition and preparation method of traditional Chinese medicine composition
12/05/2012CN102805772A Application of coptis chinensis, amur cork-tree bark, Chinese rhubarb and skullcap dysentery inhibiting particles to preparation of medicines for treating intestinal diseases of poultry, and medicinal composition formed by compounding particles
12/05/2012CN102805767A Heat stranguria removal granule raw material polygonum capitatum extract with anti-gonococcus effect
12/05/2012CN102805763A Preparation method of plant-based slow-release compound antibacterial agent for prevention and control of skin ulcer syndrome of Apostichopus japonicus
12/05/2012CN102805748A Pazufloxacin mesilate medicinal preparation and preparation method thereof
12/05/2012CN102805747A Use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and pharmaceutically acceptable salt or derivative of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine in pharmacy
12/05/2012CN102805731A Posaconazole dry suspension and preparation method thereof
12/05/2012CN102805725A Azlocillin sodium medicinal composition for injection and preparation method for azlocillin sodium medicinal composition for injection